Procurement of Pharmaceuticals

EthiopianTenders notice for Procurement of Pharmaceuticals. The reference ID of the tender is 76057365 and it is closing on 28 Dec 2022.

100% Secure Payments

Tender Details

  • Country: Ethiopia
  • Summary: Procurement of Pharmaceuticals
  • ETT Ref No: 76057365
  • Deadline: 28 Dec 2022
  • Competition: NCB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: NCB/EPSA6/RDF-R/PH/04/22
  • Purchaser's Detail :
  • Purchaser : ETHIOPIAN PHARMACEUTICALS MANUFACTURING S.C
    Ethiopia Pharmaceuticals Manufacturing s.c Addis Ababa, Ethiopia Tel: +251 11 371 9941; +251 11 371 1000; +251 11 371 2574 Fax: +251 11 371 2088
    Email :epharm@ethionet.et/pfsa@ethionet.et
    URL :www.pfsa.gov.et

  • Description :
  • Tenders are invited for Procurement of Pharmaceuticals. Bid closing date: on or before opening date and time (within 15 days from the date of floating on Addis Zemen News letter, Bid opening date: Dec 31, 2022 Region: Addis Ababa Bid document price: 100 birr Bid bond: ETB 500,000
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
EthiopianTenders Features

EthiopianTenders Features

Fresh and verified Tenders from Ethiopian. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Ethiopian in your email inbox.

  Chat with us